Medifacts International Announces Appointment of Michael E. Woehler as Chief Executive Officer
CEO transition positions Medifacts for growth and expansion
ROCKVILLE, MARYLAND (USA) / LANGENFELD, GERMANY– October 31, 2006 – Medifacts International, a global provider of clinical research and cardiac safety services, announced today that Michael E. Woehler, PhD has been named as the Company's new President and Chief Executive Officer.
Dr. Woehler has had more than 25 years of experience in leading global businesses in the life sciences and CRO industries. Most recently, he served as the Executive Vice President of PAREXEL International Corporation where he was responsible for the Worldwide Consulting, Medical Marketing Services and Clinical Pharmacology business, Corporate Services, and the Corporate Quality divisions. Dr. Woehler also served as PAREXEL's Senior Vice President and President of Clinical Research Services for four years where he managed 3000 employees worldwide.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
